Clinical Trials in San Antonio

Showing 4681-4700 of 14,633 trials

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

NCT05532735

Open-label, dose ascending safety, tolerability, and proof of concept study to evaluate the use of ANXV (human recombinant Annexin A5) in the treatment of subjects with recently diagnosed Retinal Vein Occlusion.

Retinal Vein Occlusion

Annexin Pharmaceuticals AB16 participantsStarted Aug 2022

West Monroe, Louisiana, United States • Hagerstown, Maryland, United States • Tulsa, Oklahoma, United States +4 more locations

COMPLETEDPhase 1< 1 mile

A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

NCT06310616

This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.

HIV Infections

ViiV Healthcare26 participantsStarted Mar 2024

San Antonio, Texas, United States

TERMINATEDPhase 3< 1 mile

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

NCT06128369

The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.

Inflammation EyePain, PostoperativeCataract

Oculis117 participantsStarted Dec 2023

Inglewood, California, United States • Morrow, Georgia, United States • Louisville, Kentucky, United States +9 more locations

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Find Trials by Condition in San Antonio

Pragmatic Trial Examining Oxygenation Prior to Intubation

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Osia 2 Pediatric Expansion Study

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

SpineJack System Postmarket Registry

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness